Conference Series LLC Ltd, invites all the participants across the globe to attend “20th International Conference on Medicinal Chemistry and Rational Drugs” during July 25-26, 2018 in Vancouver, Canada which includes prompt Keynote presentations, Oral talks, Poster presentations, and Exhibitions.
This International Conference on Medicinal Chemistry and Rational Drugs focus on the importance to understand drugs therapeutic, Cell Line Development and alternatives in the Research and Teachings, thus how can we maximize the use of cell line models and also various other monitoring aspects in research and development. It is with better understandings not only one can know the traditional methods of pharmacology but also the Clinical Trails and Experimental approaches in research without the usage of animals and on the other hand with the use of Cell Line models. More research in pharmacology deals with identifying and research in Drug Development, Cell Line Preservation and usage in the long run, in vitro, in silico models, noninvasive techniques, micro-dosing. More interestingly the Traditional ways of Drug Designing and the biotechnology research now resulting in the Advancement and new trends.
Join us in Vancouver, Canada for the International Conference on Medicinal Chemistry and Rational Drugs.
Find the latest developments and new strategies in New Era: A Bottom Line Research and Development, such as Drug Development, new Drugs innovation, Ethnopharmacology, Stem cell, Cell line developments, Neuropharmacology, Cancer Pharmacology, Molecular Pharmacology, Invertebrate models. QSAR based Studies, and many related topics of Pharma research and new innovation in the research of academic, research centers and industrialization of the pharmacology and biotech.
Medicinal chemistry and Rational Drugs is a stimulating field as it links many scientific disciplines and allows for collaboration with other scientists in researching and developing new drugs. Medicinal chemists apply their chemistry training to the process of synthesizing new pharmaceuticals. They also improve the processes by which existing pharmaceuticals are made. Medicinal chemists are focused on drug discovery and development and are concerned with the isolation of medicinal agents found in plants, as well as the creation of new synthetic drug compounds.
Chemistry volumes continue to rise in the U.S. and chemical market expected to contract this year—As a result, chemical industry capital spending in the U.S. surged 12.1% in 2014 and gained 21.0% in 2015, reaching $43.58 billion and accounting for more than one-half of total construction spending by the manufacturing sector. The association representing US-based chemical producers said that US chemical production (excluding pharmaceuticals) is expected to realize the overall growth of 1.6% in 2016, followed by 4.1% growth next year, and 5.0% in 2018. Average annual gains of over 8% per year in U.S. Chemical industry capital spending are expected through 2018 with only a minor slowdown in subsequent growth expected. By 2021, ACC expects capital spending to reach $70 billion, contributing to four consecutive years of job growth in the industry. American chemistry revenues will exceed $1.0 trillion by 2020.
Chemistry Council stated that more than 275 new chemical production projects had been announced since 2010 with a total value of more than $170 billion, with a full 49% already complete or under construction; 61% of these are the foreign direct investment. By 2021, U.S. capital spending by the chemical industry will reach $65 billion—more than triple the level of spending at the start of this prolonged cycle in 2010. The trade surplus in chemicals (excluding pharmaceuticals) will grow to $36 billion this year as exports rise by 2% to $132 billion and imports hold steady at $96 billion. Two-way trade between the U.S. and its foreign partners will reach $227 billion this year and will grow steadily over the coming years.
The popularity of Formulation and Drug Delivery has increased significantly in recent years. The Drug Delivery Technology market is expected to reach USD 1,504.7 Billion by 2020 from USD 1,048.1 Billion in 2015, growing at a CAGR of 7.5% from 2015 to 2020. Drug delivery technology market offers a promising approach for the delivery of various kinds of drugs that have different molecular formulation. Drug delivery technology is aimed at maximizing the drug delivery at the targeted site so as to increase the efficiency of drug and proposing improved patient compliance.
Scope and Importance:-
MedChem and Rational Drugs is a global platform to discuss and learn about Drug Targeting, Drug Delivery Routes, Drug Delivery Systems, in Drug Delivery, Pharmaceutical Nanotechnology, Smart Drug Delivery Systems, Applications of Biomaterials, Theranostics and Peptides and Protein Drug Delivery, Organic Chemistry, Inorganic Chemistry, Analytical Chemistry, Medical Biochemistry, Physical Chemistry, Biological Chemistry, Theoretical Chemistry. Chemistry Meeting would discuss various topics related to Biochemistry, Nuclear chemistry, Polymer Chemistry, Stereochemistry, Clinical chemistry, Medicinal & pharmaceutical chemistry. Conference Series LLC Ltd, has taken the initiation to gather the world-class experts both from academic and industry in a common platform at Chemistry Conferences.
MedChem and TDD 2017, USA
Conference Series LLC Ltd, successfully organized 18th International Conference on Medicinal Chemistry & Targeted Drug Delivery during December 06-08, 2017 at Dallas, USA and received a great and fruitful response. Eminent Scientists, Researchers, Pharmacists, Industry Professionals and scholar students have made their resplendent presence and addressed the gathering.
The theme of the conference “Scientists Unlock Research: Riding Waves in Chemistry, Drug Discovery and Smart Drug Delivery.”
MedChem & TDD 2017 Organizing Committee would like to thank the Moderator of the conference, Ms. Olayide A. Arodola, University of KwaZulu-Natal, South Africa who contributed a lot to the smooth functioning of this event.
Conference Series LLC Ltd, would like to convey a great appreciation to following honorable guests and Keynote speakers.
L. Mario Amzel, Johns Hopkins University, USA
Thorsten Nowak, C4X Discovery Holdings PLC., UK
Tatsuya Takagi, Osaka University, Japan
Victor Hruby, University of Arizona, USA
Concepción González-Bello, University of Santiago de Compostela, Spain
Carsten Detering, BioSolveIT Inc., USA
Jetze J. Tepe, Michigan State University
Marc Le Borgne, University Lyon 1, France
Mitsuji Yamashita, Shizuoka University, Japan
Very Special Thanks to our Exhibitors and Sponsors to have bestowed and their faith and invested in us to make this event a fruitful one. We hope you continue your support in our future endeavors.
Conference Series LLC Ltd, also took the privilege of felicitating MedChem & CADD-2016 Organizing Committee, Editorial Board Members of Journal of Medicinal Chemistry, Journal of Drug Designing and Biochemistry & Pharmacology, Keynote Speakers, Chair and Co-Chairs and Moderator whose support made the conference a great success.
